1Department of Neurological Surgery and.
2Surgical Neurology Branch, National Institute of Neurologic Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
J Neurosurg. 2021 Jul 30;136(2):405-412. doi: 10.3171/2021.1.JNS203579. Print 2022 Feb 1.
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a common problem during the postoperative course after pituitary surgery. Although treatment of this condition is well characterized, prevention strategies are less studied and reported. The authors sought to characterize outcomes and predictive factors of SIADH after implementation of routine postoperative fluid restriction for patients undergoing endoscopic transsphenoidal surgery for pituitary adenoma.
In March 2018, routine postoperative fluid restriction to 1000 ml/day for 7 days was instituted for all patients who underwent surgery for pituitary adenoma. These patients were compared with patients who underwent surgery for pituitary adenoma between March 2016 and March 2018, prior to implementation of routine fluid restriction. Patients with preoperative history of diabetes insipidus (DI) or concern for postsurgical DI were excluded. Patients were followed by neuroendocrinologists and neurosurgeons, and sodium levels were checked between 7 and 10 days postoperatively. SIADH was defined by a serum sodium level less than 136 mmol/L, with or without symptoms within 10 days after surgery. Thirty-day readmission was recorded and reviewed to determine underlying reasons.
In total, 82 patients in the fluid-unrestricted cohort and 135 patients in the fluid-restricted cohort were analyzed. The patients in the fluid-restricted cohort had a significantly lower rate of postoperative SIADH than patients in the fluid-unrestricted cohort (5% vs 15%, adjusted OR [95% CI] 0.1 [0.0-0.6], p = 0.01). Higher BMI was associated with lower rate of postoperative SIADH (adjusted OR [95%] 0.9 [0.9-1.0], p = 0.03), whereas female sex was associated with higher rate of SIADH (adjusted OR [95% CI] 3.1 [1.1-9.8], p = 0.03). There was no difference in the 30-day readmission rates between patients in the fluid-unrestricted and fluid-restricted cohorts (4% vs 7%, adjusted OR [95% CI] 0.5 [0-5.1], p = 0.56). Thirty-day readmission was more likely for patients with history of hypertension (adjusted OR [95% CI] 5.7 [1.3-26.3], p = 0.02) and less likely for White patients (adjusted OR [95% CI] 0.3 [0.1-0.9], p = 0.04).
Routine fluid restriction reduced the rate of SIADH in patients who underwent surgery for pituitary adenoma but was not associated with reduction in 30-day readmission rate.
抗利尿激素分泌不当综合征(SIADH)是垂体手术后常见的术后并发症。尽管对该病症的治疗已有明确的描述,但预防策略的研究和报道较少。作者旨在探讨内镜经蝶窦垂体瘤切除术患者术后常规限制液体摄入前后,SIADH 的发生率和预测因素。
2018 年 3 月,对所有行垂体瘤切除术的患者术后 7 天内每天限制液体摄入 1000ml,开始实施该方案。将该方案实施前后(2016 年 3 月至 2018 年 3 月)行垂体瘤切除术的患者作为对照组。术前有尿崩症(DI)病史或术后有 DI 担忧的患者被排除。由神经内分泌学家和神经外科医生对患者进行随访,术后 7-10 天检测血清钠水平。术后 10 天内血清钠水平<136mmol/L,无论是否有症状,均定义为 SIADH。记录并分析 30 天内再入院的潜在原因。
共纳入 82 例无液体限制组和 135 例液体限制组患者。液体限制组术后 SIADH 的发生率显著低于无液体限制组(5% vs 15%,校正 OR [95%CI]0.1 [0.0-0.6],p = 0.01)。较高的 BMI 与术后 SIADH 的发生率较低相关(校正 OR [95%]0.9 [0.9-1.0],p = 0.03),而女性患者 SIADH 的发生率较高(校正 OR [95%CI]3.1 [1.1-9.8],p = 0.03)。无液体限制组和液体限制组患者 30 天内再入院率无差异(4% vs 7%,校正 OR [95%CI]0.5 [0-5.1],p = 0.56)。有高血压病史的患者(校正 OR [95%CI]5.7 [1.3-26.3],p = 0.02)和白人患者(校正 OR [95%CI]0.3 [0.1-0.9],p = 0.04)30 天内再入院的可能性较低。
对行垂体瘤切除术的患者常规限制液体摄入可降低 SIADH 的发生率,但与 30 天内再入院率的降低无关。